Search form

Reg-ent℠ 2021 Quality Measures

Reg-ent℠ 2021 Quality Measures

Quality measures are used to track patient care, connect outcomes with processes, and meet third-party payer requirements, such as the Merit-based Incentive Payment System (MIPS). Reg-ent allows participants to track performance and benchmark against peers in Reg-ent for specialty-specific (i.e., QCDR) and public (i.e., QPP) measures.

Qualified Clinical Data Registry (QCDR) Measures

Age-related Hearing Loss
AAO16: Age-related Hearing Loss: Audiometric Evaluation+

Allergic Rhinitis
AAO23: Allergic Rhinitis: Intranasal Corticosteroids or Oral Antihistamines
AAO24: Allergic Rhinitis: Avoidance of Leukotriene Inhibitors+

Bell's Palsy
AAO13: Bell's Palsy: Inappropriate Use of Magnetic Resonance Imaging or Computed Tomography Scan (Inverse Measure)+

Dysphonia
AAO34: Dysphonia: Postoperative Laryngeal Examination 

Otitis Media with Effusion (OME)
AAO21: Otitis Media with Effusion: Hearing Test for Chronic OME > 3 months
AAO31: Otitis Media with Effusion (OME): Avoidance of Inappropriate Use of Medications+

Tympanostomy Tubes
AAO12: Tympanostomy Tubes: Topical Ear Drop Monotherapy Acute Otorrhea+
AAO20: Tympanostomy Tubes: Hearing Test+
AAO36: Tympanostomy Tubes: Resolution of Otitis Media with Effusion in Adults and Children+*

Neurotology
AAO29: Quality of Life for Patients with Neurotology Disorders+*
AAO32: Standard BPPV Management+
AAO35: Benign Positional Paroxysmal Vertigo (BPPV): Dix-Hallpike and Canalith Repositioning

Rhinoplasty
ASPS16: Airway Assessment for patients undergoing Rhinoplasty+
ASPS17: Patient Satisfaction with Rhinoplasty Procedure+*
ASPS18: Shared-decision making for post-operative management of discomfort following Rhinoplasty+

Reconstruction After Skin Cancer Resection

ASPS22: Coordination of Care for Anticoagulated Patients Undergoing Reconstruction After Skin Cancer Resection+
ASPS24: Visits to the ER or Urgent Care Following Reconstruction After Skin Cancer Resection+
ASPS26: Patient Satisfaction with Information Prior to Facial Reconstruction After Skin Cancer Resection Procedures+
ASPS27: Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Procedures+
ASPS28: Continuation of Anticoagulation Therapy in the Office-based Setting for Closure and Reconstruction After Skin Cancer Resection Procedures+
ASPS29: Avoidance of Opioid Prescriptions for Closure and Reconstruction After Skin Cancer Resection+

Quality Payment Program (QPP) Public Measures

Acute Otitis Externa
QPP093: Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy – Avoidance of Inappropriate Use+

Adult Sinusitis
QPP331: Adult Sinusitis: Antibiotic Prescribed for Acute Viral Sinusitis (Overuse)+
QPP332: Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis (Appropriate Use)+

Asthma
QPP398: Optimal Asthma Control*+
QPP444: Medication Management for People with Asthma+

Falls
QPP154: Falls: Risk Assessment+
QPP155: Falls: Plan of Care+

Medication
QPP130: Documentation of Current Medications in the Medical Record^+
QPP238: Use of High-Risk Medications in Older Adults^+

Opioid Therapy
QPP468: Continuity of Pharmacotherapy for Opioid Use Disorder (OUD)+

Otitis Media with Effusion
QPP464: Otitis Media with Effusion: Systemic Antimicrobials - Avoidance of Inappropriate Use+

Perioperative Care
QPP021: Perioperative Care: Selection of Prophylactic Antibiotic – First OR Second-Generation Cephalosporin+
QPP023: Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients)+

Preventive Care & Screening
QPP110: Preventive Care and Screening: Influenza Immunization^
QPP111: Pneumococcal Vaccination Status for Older Adults^
QPP128: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan^
QPP226: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention^
QPP317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented^
QPP402: Tobacco Use and Help with Quitting Among Adolescents
QPP431: Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling

Respiratory Diseases
QPP065: Appropriate Treatment for Upper Respiratory Infection (URI) ^+
QPP066: Appropriate Testing for Pharyngitis^+
QPP116: Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis+

Skin Cancer
QPP440: Skin Cancer: Biopsy Reporting Time – Pathologist to Clinician+

Surgery
QPP355: Unplanned Reoperation within the 30 Day Postoperative Period*+
QPP356: Unplanned Hospital Readmission within 30 Days of Principal Procedure*+
QPP357: Surgical Site Infection (SSI)*+
QPP358: Patient-Centered Surgical Risk Assessment and Communication+

Sleep Apnea
QPP277: Sleep Apnea: Severity Assessment at Initial Diagnosis
QPP279: Sleep Apnea: Assessment of Adherence to Positive Airway Pressure Therapy

Other
QPP047: Advance Care Plan+
QPP261: Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness+
QPP265: Biopsy Follow-Up+
QPP374: Closing the Referral Loop: Receipt of Specialist Report^+
QPP404: Anesthesiology Smoking Abstinence+

*Denotes Outcome Measure
+Denotes High Priority Measure
^Denotes eCQM